Current management and future directions in metastatic pancreatic adenocarcinoma

Of the anticipated 50,000 individuals expected to be diagnosed with pancreatic cancer in 2016, the majority will have metastatic disease. Given the noncurative nature of advanced pancreatic adenocarcinoma, treatment is aimed at inducing disease regression, controlling symptom, and extending life. Th...

Celý popis

Podrobná bibliografie

Vydáno v:	Cancer Ročník 122; číslo 24; s. 3765 - 3775
Hlavní autoři:	Varghese, Anna M., Lowery, Maeve A., Yu, Kenneth H., O'Reilly, Eileen M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 15.12.2016
Témata:	Adenocarcinoma - drug therapy Animals Antineoplastic Combined Chemotherapy Protocols - therapeutic use chemotherapy Humans metastatic pancreatic cancer Pancreatic Neoplasms - drug therapy targets treatment standards pancreatic cancer treatment standards metastatic chemotherapy targets
ISSN:	0008-543X, 1097-0142
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!